Related Experiment Video
Updated: Mar 12, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho
Shunsuke Yamada1, Cecilia M Giachelli1
1Department of Bioengineering, University of Washington, Seattle, WA 98195, USA.
Insights
Vascular calcification (VC) is common in chronic kidney disease (CKD). FGF23 and α-Klotho may impact VC, with α-Klotho showing a protective role, potentially offering new therapeutic avenues for CKD-mineral and bone disorder.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Biochemistry
Background:
- Vascular calcification (VC) is prevalent in aging, diabetes mellitus, and chronic kidney disease (CKD), significantly predicting cardiovascular morbidity and mortality in CKD patients.
- Pathological mechanisms of VC include vascular smooth muscle cell osteochondrogenic differentiation, apoptosis, extracellular vesicle release, and elastin degradation.
- Elevated serum phosphate in CKD accelerates mineral deposition in the vasculature and heart valves.
Purpose of the Study:
- To investigate the roles of α-Klotho and fibroblast growth factor 23 (FGF23) in the pathogenesis of uremic vascular calcification (VC) within the context of CKD-mineral and bone disorder (CKD-MBD).
- To clarify the conflicting reports on FGF23's effects on VC and consolidate evidence for α-Klotho's protective role.
- To identify potential therapeutic targets by evaluating the interplay of phosphate, FGF23, and α-Klotho in VC.
Main Methods:
- Review and synthesis of existing literature on vascular calcification, CKD-MBD, FGF23, and α-Klotho.
- Analysis of discordant and supporting evidence regarding the effects of FGF23 and α-Klotho on VC.
- Exploration of the systemic interplay between phosphate, FGF23, and α-Klotho in VC pathogenesis.
Main Results:
- Evidence suggests FGF23 has discordant effects on VC, requiring further investigation.
- Mounting evidence supports a protective role for α-Klotho in vascular calcification.
- Further research is needed to elucidate the synthesis and precise roles of FGF23 and α-Klotho in normal and diseased states.
Conclusions:
- α-Klotho demonstrates a protective role against vascular calcification, offering a potential therapeutic target.
- Further elucidation of FGF23's role and the combined action of FGF23 and α-Klotho is crucial for understanding uremic VC.
- Systemic evaluation of phosphate, FGF23, and α-Klotho interactions may yield novel therapeutic strategies for CKD-MBD patients.
Abstract:
Vascular calcification (VC) is highly prevalent in aging, diabetes mellitus, and chronic kidney disease (CKD). VC is a strong predictor of cardiovascular morbidity and mortality in the CKD population. Complex pathological mechanisms are involved in the development of VC, including osteochondrogenic differentiation and apoptosis of vascular smooth muscle cells, instability and release of extracellular vesicles loaded calcium and phosphate, and elastin degradation. Elevated serum phosphate is a late manifestation of CKD, and has been shown to accelerate mineral deposition in both the vessel wall and heart valves. α-Klotho and fibroblast growth factor 23 (FGF23) are emerging factors in CKD-mineral and bone disorder (CKD-MBD) and are thought to be involved in the pathogenesis of uremic VC. There are discordant reports regarding the biomedical effects of FGF23 on VC. In contrast, mounting evidence supports a well-supported protective role for α-Klotho on VC. Further studies are warranted to elucidate potential roles of FGF23 and α-Klotho in VC and to determine where and how they are synthesized in normal and disease conditions. A thorough systemic evaluation of the biomedical interplay of phosphate, FGF23, and α-Klotho may potentially lead to new therapeutic options for patients with CKD-MBD.
Related Concept Videos
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily...
Skeleton and Calcium Homeostasis
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Osteoclasts in Bone Remodeling
Introduction to Electrolytes
Role of Sodium
One...

